Literature DB >> 26365834

Colorimetric and fluorescence detection of G-quadruplex nucleic acids with a coumarin-benzothiazole probe.

Jin-wu Yan1, Yi-guang Tian, Jia-heng Tan, Zhi-shu Huang.   

Abstract

A colorimetric and red-emitting fluorescent dual probe for G-quadruplexes was devised with a conjugated coumarin-benzothiazole scaffold. Its significant and distinct changes in both color and fluorescence enable the label-free and visual detection of G-quadruplex structures. In addition, this probe gives a distinct strong emission response to the nucleoli in fixed cells imaging, which might be attributed to the interaction between the probe and rDNA G-quadruplex based on the chromatin immunoprecipitation assay. All these results suggest its promising application prospects in the G-quadruplex research field.

Entities:  

Mesh:

Substances:

Year:  2015        PMID: 26365834     DOI: 10.1039/c5an01573a

Source DB:  PubMed          Journal:  Analyst        ISSN: 0003-2654            Impact factor:   4.616


  4 in total

1.  Colorimetric detection of DNA at the nanomolar level based on enzyme-induced gold nanoparticle de-aggregation.

Authors:  Qingling Liu; Li Li; Yan Zhao; Zhengbo Chen
Journal:  Mikrochim Acta       Date:  2018-05-15       Impact factor: 5.833

2.  Subtle structural alterations in G-quadruplex DNA regulate site specificity of fluorescence light-up probes.

Authors:  Rajendra Kumar; Karam Chand; Sudipta Bhowmik; Rabindra Nath Das; Snehasish Bhattacharjee; Mattias Hedenström; Erik Chorell
Journal:  Nucleic Acids Res       Date:  2020-02-20       Impact factor: 16.971

3.  8-Styryl-substituted coralyne derivatives as DNA binding fluorescent probes.

Authors:  P M Pithan; D Decker; S I Druzhinin; H Ihmels; H Schönherr; Y Voß
Journal:  RSC Adv       Date:  2017-02-08       Impact factor: 3.361

4.  Recognition of G-quadruplex topology through hybrid binding with implications in cancer theranostics.

Authors:  Yelisetty Venkata Suseela; Pardhasaradhi Satha; N Arul Murugan; Thimmaiah Govindaraju
Journal:  Theranostics       Date:  2020-08-20       Impact factor: 11.556

  4 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.